Pralmorelin Performance Benchmark Growth Hormone Releasing Peptide
- Mechanism: Acts as a potent GH Secretagogue via the ghrelin receptor pathway.
- Application: Ideal Research Compound for metabolic and diagnostic studies.
- Supply: Industrial Scale production with verified COA and High Purity standards.
Pralmorelin, frequently identified in technical literature as Growth Hormone Releasing Peptide-2 (GHRP-2), represents a critical class of Synthetic Peptide designed to stimulate endogenous growth hormone secretion. As a Peptidomimetic, it mimics the action of ghrelin, the endogenous ligand for the growth hormone secretagogue receptor (GHS-R). For formulation engineers and procurement specialists, understanding the performance benchmark of this molecule is essential for ensuring consistency in research applications. NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier Global Manufacturer dedicated to supplying this material with strict adherence to quality protocols.
Mechanism of Action and Physiological Impact
The primary function of Pralmorelin is to act as an agonist at the GHS-R, commonly referred to as the ghrelin receptor. This mechanism is distinct from growth hormone-releasing hormone (GHRH), as it operates through a separate receptor pathway located in the anterior pituitary gland and hypothalamus. By binding to these receptors, the peptide triggers the release of growth hormone (GH) in a pulsatile manner. This pulsatility is crucial for maintaining physiological signaling patterns that regulate protein synthesis, lipolysis, and skeletal growth.
Beyond direct GH stimulation, this Growth Hormone Releasing Peptide influences other hormonal axes. Technical data indicates it can increase levels of adrenocorticotropic hormone (ACTH) and cortisol, though these effects are generally secondary to its primary GH-stimulating capabilities. Furthermore, the compound has been observed to stimulate appetite through hypothalamic pathways, making it a valuable Research Compound for studies involving cachexia or metabolic regulation. The ability to enhance lean body mass while reducing fat mass suggests significant potential for metabolic research.
Performance Benchmarking and Stability
When evaluating the performance benchmark of Pralmorelin against other secretagogues, several key metrics emerge. Studies have demonstrated that this peptide stimulates GH secretion effectively, often showing superior potency compared to earlier generations of secretagogues. The stability of the molecule is a critical factor for formulation. As a Synthetic Peptide, it requires specific handling to maintain integrity during storage and reconstitution.
For laboratories sourcing materials, verifying the High Purity of the batch is non-negotiable. Impurities can alter the pharmacokinetic profile and skew research data. NINGBO INNO PHARMCHEM CO.,LTD. ensures that every batch undergoes rigorous testing to meet international standards for research chemicals. This commitment to quality allows researchers to rely on consistent data across multiple experimental cycles.
Key Technical Specifications
The following table outlines the standard technical specifications expected for industrial and laboratory-grade Pralmorelin. These benchmarks serve as a guideline for quality assurance teams during incoming inspection.
| Parameter | Specification | Test Method |
|---|---|---|
| Product Name | Pralmorelin (GHRP-2) | N/A |
| CAS Number | 158861-67-7 | N/A |
| Molecular Formula | C45H55N9O6 | N/A |
| Purity | >98.0% | HPLC |
| Appearance | White Lyophilized Powder | Visual |
| Storage Condition | -20°C, Desiccated | N/A |
| Documentation | COA, MSDS, HPLC Chromatogram | QC Department |
Formulation Considerations and Sourcing
In a research setting, the solubility and stability of the peptide in solution are paramount. Pralmorelin is typically supplied as a lyophilized powder which must be reconstituted with bacteriostatic water or appropriate buffers prior to use. It is sensitive to repeated freeze-thaw cycles, so aliquoting is recommended for long-term storage. When sourcing high-purity Lab Reagent, buyers should prioritize suppliers who provide comprehensive documentation, including a Certificate of Analysis (COA).
The commercial availability of this peptide has expanded due to increased demand in metabolic and diagnostic research. However, not all suppliers operate at an Industrial Scale capable of maintaining batch-to-batch consistency. A reliable Global Manufacturer will offer transparent pricing structures and Bulk Price options for large-scale studies without compromising on quality control. The ability to trace the synthesis history and verify the absence of heavy metals or microbial contamination is a key differentiator in the supply chain.
Regulatory and Research Context
While Pralmorelin has been investigated for diagnostic use in certain regions to assess growth hormone deficiency, its therapeutic applications remain subject to ongoing research and regulatory approvals. In a laboratory environment, it is classified strictly as a research chemical. Researchers must adhere to local compliance guidelines regarding the handling of bioactive peptides. The compound's ability to overcome inhibitory factors such as elevated cortisol or glucose levels makes it a robust tool for studying the hypothalamic-pituitary axis under stress conditions.
Furthermore, the peptide's interaction with sleep-wake cycles and energy balance provides a rich avenue for investigation. Unlike endogenous ghrelin, which fluctuates with feeding states, exogenous administration allows for controlled stimulation of the GHS-R. This control is vital for isolating variables in complex physiological studies. Ensuring the material is free from endotoxins is particularly important when investigating immune responses or inflammatory pathways.
Conclusion
Pralmorelin remains a potent stimulator of growth hormone release, operating through the ghrelin receptor pathway with high specificity. Its ability to enhance GH levels, stimulate appetite, and potentially confer metabolic benefits makes it a compound of significant interest in both clinical and research settings. For procurement teams and principal investigators, securing a supply chain that guarantees High Purity and consistent performance is essential. NINGBO INNO PHARMCHEM CO.,LTD. provides the technical support and manufacturing capacity required to meet these demanding standards, ensuring that research outcomes are driven by data quality rather than material variability.